ReviewSpecialized roles of neurofilament proteins in synapses: Relevance to neuropsychiatric disorders
Introduction
Neurofilaments (NFs), the intermediate filaments of mature neurons, are among the most abundant proteins in brain. Unlike the intermediate filaments of other cell types, which are usually homopolymers, NFs in the CNS are hetero-polymers composed of NFL, NFM, NFH and alpha-internexin subunits (Yuan et al., 2006). Although structurally distinctive, these four NF subunits share a basic tripartite domain structure consisting of a conserved central α-helical rod region, a short variable head domain at the amino-terminal end and a tail of highly variable length at the C-terminal end. The short head domain is rich in serine and threonine residues and contains consensus sites for O-linked glycosylation and phosphorylation (Yuan et al., 2012a). The central rod domain, which is relatively conserved among intermediate filament family members, contains long stretches of hydrophobic heptad repeats favoring formation of α-helical coiled-coil dimers. The C-terminal domains contain glutamic- and lysine-rich stretches of varying length that mainly establish the size range (58–200 kDa on SDS gels) of the four NF subunits. Although all intermediate filament types serve roles as structural scaffolds, NF subunit heterogeneity also confers specialized structural properties to NF, in axons where the filaments are extremely long and are often arranged in parallel with uniform spacing conferred by the long C-terminal tails of NFM and NFH extending perpendicularly from the filament core (Rao et al., 2003, Rao et al., 2002). These unique space filling properties of NF facilitate their well-established role in caliber expansion of large-diameter myelinated axons of peripheral nerves, which is critical for effective nerve conduction (Zhu et al., 1997). NFs also extensively cross-link with other cytoskeletal elements along axons to form a large metabolically stable stationary NF network (Nixon and Logvinenko, 1986, Yuan et al., 2015a, Yuan et al., 2009) that is critical to axon caliber expansion (Friede and Samorajski, 1970, Hoffman et al., 1987, Ohara et al., 1993) and organelle distribution along axons (Rao et al., 2011).
Besides these unique structural and functional features, NF subunits are distinguished from other intermediate filament proteins by the complex regulation of their head and tail domains by phosphorylation, especially those of NFM and NFH, which involves actions of multiple protein kinases and phosphatases at many polypeptide sites (Pant and Veeranna, 1995). Although certain phosphorylation events are known to control tail extension and subunit assembly and slow turnover, the purpose of such complex and dynamically changing phosphate topography on NF subunits (de Waegh et al., 1992, Nixon and Sihag, 1991, Pant and Veeranna, 1995) has remained puzzling, given the mainly static structural support roles ascribed to NF. Both the complex hetero-polymeric structure and dynamically changing phosphate topography of NF proteins suggests that individual NF proteins might serve additional biological roles although there has been relatively little exploration of this issue until recently.
NF gene mutations are well recognized as causes of several neurological disorders mainly involving degeneration of peripheral nerve fibers in accordance with the prominent function of NF in supporting large-diameter myelinated axons (Brownlees et al., 2002). Notably, however, NF proteins are abundant in grey matter CNS regions as well as white matter (Chan et al., 1997) but influence caliber expansion much less dramatically in most populations of CNS axons (Dyakin et al., 2010). These observations and evidence that NF subunits can be axonally transported in various minimally assembled forms (including as heterodimers) suggest a broader distribution and range of assembly forms of NF subunits within CNS neurons, including substantial populations in synapses. In light of these findings, alterations of a particular NF subunit as seen in specific brain regions in psychiatric and neuropsychiatric disorders (Cairns et al., 2003, Clinton et al., 2004, Garcia-Sevilla et al., 1997) may reflect an alteration within synapses which influences the clinical phenotype.
Psychiatric diseases, affecting an estimated 54 million Americans yearly, cause mild to severe disturbances in thought or behavior usually in the absence of known changes in axonal integrity. Nevertheless, changes in levels and phosphorylation of NF subunits have consistently been noted in certain psychiatric disorders although the location of these changes within neurons is poorly understood. Psychiatric diseases prominently involve alterations of synaptic transmission. The highly specialized composition of synapses includes not only the well characterized vesicular and protein receptor machinery supporting neurotransmission but also a specialized cytoskeleton important for delivering, inserting, and recycling synaptic components. Like other domains in a neuron, the cytoskeleton in synapses is composed of microtubules, actin filaments, the spectrin-rich membrane skeleton, and as recently shown, NF assemblies (Yuan et al., 2015b, Yuan et al., 2015c). Evidence is also emerging that the cytoskeleton, and especially the NF scaffold, acts as a docking platform to organize the topography of organelles within different neuronal compartments. Rearrangements of this topography are dynamically coordinated at least in part by cellular signals regulating the phosphorylation state of the binding partners (Perrot and Julien, 2009, Rao et al., 2011, Styers et al., 2004, Yuan et al., 2015b). Such evidence suggests a range of possibilities for understanding the newly recognized roles of individual NF subunits in modulating synaptic function. In this review, we consider the properties of synaptic NF assemblies in the CNS and, in this context, raise the possibility that certain changes in levels or phosphorylation of NF subunits reported in neuropsychiatric disorders (Table 1) disrupt synaptic signaling or, in some cases, reflect adaptive or maladaptive responses to these synaptic disruptions.
Section snippets
Distinctive assemblies of NF subunits in synapses
Synapses have long been considered to be degradative sites for NF reaching terminals by axonal transport (Roots, 1983). When NF proteins have been detected in synaptic fractions and bound to synaptic proteins in vitro, they have previously been viewed as contaminating axonal NF proteins (Matus et al., 1980) and their possible role in synapses has rarely been entertained. Using multiple independent approaches, however, Yuan et al. recently provided definitive evidence that all four CNS NF
Schizophrenia and bipolar disorder
Schizophrenia, a severe chronic brain disorder affecting ∼1% of the population (Perala et al., 2007), is characterized by abnormal interpretation of reality and social behavior. The behavioral syndrome reflects a combination of positive symptoms (eg. hallucinations, delusions, and disordered thinking and behavior), negative symptoms (eg. reduced expression, feelings, and speech production), and cognitive deficits (eg. poor executive functioning, working memory, and attention). The causes of
Alterations of NF proteins in Alzheimer’s disease
Alzheimer’s disease is an irreversible, degenerative brain disorder that progressively destroys memory and other mental functions. Early striking loss of synaptic connections within brain regions involved in memory and thinking skills is followed by loss of neurons of many types. Accompanying neurodegenerative changes is the development of defining neuropathological hallmarks of AD, neuritic plaques, and neurofibrillary tangles, along with extracellular deposition of ß-amyloid. The causes of
Conclusion
The etiology of major neuropsychiatric disorders critically involves dysfunction of synapses and, in late-onset dementias, the ultimate loss of synapses early in the disease. Relatively little attention, however, has been paid to the dynamics of cytoskeletal proteins at synaptic terminals and particularly the possible synaptic involvement of NF proteins. Until recently, the functioning of NF protein assemblies within synapses has been unappreciated and the focus has been on their axonal roles
Acknowledgements
This work was supported by Grant 5R01AG005604 from the National Institutes on Aging.
The authors declare that there are no conflicts of interest.
References (192)
- et al.
The formation of synaptic junctions in developing rat brain: a quantitative electron microscopic study
Brain Res.
(1967) - et al.
Caspase-3 cleaved spectrin colocalizes with neurofilament-immunoreactive neurons in Alzheimer's disease
Neuroscience
(2006) - et al.
Sensitization of the mesoaccumbens dopamine response to nicotine
Pharmacol. Biochem. Behav.
(1998) - et al.
Patients with Alzheimer disease have elevated intrathecal synthesis of antibodies against tau protein and heavy neurofilament
J. Neuroimmunol.
(2012) - et al.
Identification and validation of novel spinophilin-associated proteins in rodent striatum using an enhanced ex vivo shotgun proteomics approach
Mol. Cell. Proteomics
(2010) - et al.
Induction of peripherin expression in subsets of brain neurons after lesion injury or cerebral ischemia
Brain Res.
(2002) - et al.
Staging of Alzheimer's disease-related neurofibrillary changes
Neurobiol. Aging
(1995) - et al.
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
Brain Res. Brain Res. Rev.
(2000) - et al.
Chronic nicotine treatment decreases neurofilament immunoreactivity in the rat ventral tegmental area
Eur. J. Pharmacol.
(2000) - et al.
Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions
Neurosci. Lett.
(2003)
Heterogeneous expression of neurofilament proteins in forebrain and cerebellum during development: clinical implications for spinocerebellar ataxia
Brain Res.
Anti-neuronal antibodies similar to those found in Alzheimer's disease induce memory dysfunction in rats
Neuroscience
Tau protein is involved in morphological plasticity in hippocampal neurons in response to BDNF
Neurochem. Int.
Glutamate induces rapid loss of axonal neurofilament proteins from cortical neurons in vitro
Exp. Neurol.
Neurofilament subunit protein abnormalities in the thalamus in schizophrenia
Thalamus Relat. Syst.
Molecular characterization of the dendritic growth cone: regulated mRNA transport and local protein synthesis
Neuron
Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells
Cell
A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease
J. Neurol. Sci.
The contributions of myelin and axonal caliber to transverse relaxation time in shiverer and neurofilament-deficient mouse models
Neuroimage
Neurofilament light gene deletion exacerbates amyloid, dystrophic neurite, and synaptic pathology in the APP/PS1 transgenic model of Alzheimer's disease
Neurobiol. Aging
Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors
J. Biol. Chem.
Neurofilament proteins and cAMP pathway in brains of mu-, delta- or kappa-opioid receptor gene knock-out mice: effects of chronic morphine administration
Neuropharmacology
Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration
Neuron
Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients
Neurosci. Lett.
Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models
Cell
Acute and chronic effects of morphine and naloxone on the phosphorylation of neurofilament-H proteins in the rat brain
Neurosci. Lett.
Identification and verification of novel rodent postsynaptic density proteins
Mol. Cell. Proteomics
Up-regulation of peripherin is associated with alterations in synaptic plasticity in CA1 and CA3 regions of hippocampus
Neurobiol. Dis.
Glutamate slows axonal transport of neurofilaments in transfected neurons
J. Cell Biol.
Spinophilin, a novel protein phosphatase 1 binding protein localized to dendritic spines
Proc. Natl. Acad. Sci. U. S. A.
Monoclonal antibodies show that neurofibrillary tangles and neurofilaments share antigenic determinants
Nature
Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease
Neurology
Neurofilament light chain in blood and CSF as marker of disease progression in mouse models and in neurodegenerative diseases
Neuron
Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia
Mol. Psychiatry
Neurofilament proteins NF-L, NF-M and NF-H in brain of patients with Down syndrome and Alzheimer's disease
Amino Acids
Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction
Proc. Natl. Acad. Sci. U. S. A.
Age-dependent targeting of protein phosphatase 1 to Ca2+/calmodulin-dependent protein kinase II by spinophilin in mouse striatum
PLoS One
Neurofilament proteins and the mesolimbic dopamine system: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area
J. Neurosci.
Compartmentation of alpha-internexin and neurofilament triplet proteins in cultured hippocampal neurons
J. Neurocytol.
Regulation of ERK (extracellular signal regulated kinase) part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine
J. Neurosci.
Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease
Arch. Neurol.
A synaptic model of memory: long-term potentiation in the hippocampus
Nature
The structure of postsynaptic densities isolated from dog cerebral cortex. II. Characterization and arrangement of some of the major proteins within the structure
J. Cell Biol.
Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain
Br. J. Pharmacol.
The neurofilament heavy chain (NfH) in the cerebrospinal fluid diagnosis of Alzheimer's disease
Dement. Geriatr. Cogn. Disord.
Selective distribution of the 57 kDa neural intermediate filament protein in the rat CNS
J. Neurosci.
Charcot-Marie-Tooth disease neurofilament mutations disrupt neurofilament assembly and axonal transport
Hum. Mol. Genet.
Loss of protein kinase C-alpha beta in brain of heroin addicts and morphine-dependent rats
J. Neurochem.
Phosphorylation of tau and neurofilament in prefrontal cortex of rat brain after acute and chronic morphine administration
Chin. J. Pathophysiol.
Alzheimer's disease antibodies bind specifically to a neurofilament protein in Torpedo cholinergic neurons
J. Neurosci.
Cited by (62)
Targeting the cytoskeleton as a therapeutic approach to substance use disorders
2024, Pharmacological ResearchPosttranscriptional regulation of neurofilament proteins and tau in health and disease
2023, Brain Research BulletinCitation Excerpt :Nf proteins (NfPs) have also recently found to play unique roles in synapse function (Yuan et al., 2015). Specifically, Nf subunits can be transported from soma to synaptic terminals in oligomeric form, including heterodimers (Yuan et al., 2003) or portions of them could be synthesized locally (Yuan and Nixon, 2016). The Nf network comprising heterodimers, oligomers and short filaments could function as a regulatory scaffold for reversible organelle and protein complex docking (Rao et al., 2011; Yuan et al., 2015).